Definitive Healthcare (DH) Competitors $4.10 -0.08 (-1.91%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends DH vs. EXFY, TUYA, LPSN, JAMF, NABL, OPRA, PD, IAS, MLNK, and SPTShould you be buying Definitive Healthcare stock or one of its competitors? The main competitors of Definitive Healthcare include Expensify (EXFY), Tuya (TUYA), LivePerson (LPSN), Jamf (JAMF), N-able (NABL), Opera (OPRA), PagerDuty (PD), Integral Ad Science (IAS), MeridianLink (MLNK), and Sprout Social (SPT). Definitive Healthcare vs. Expensify Tuya LivePerson Jamf N-able Opera PagerDuty Integral Ad Science MeridianLink Sprout Social Expensify (NASDAQ:EXFY) and Definitive Healthcare (NASDAQ:DH) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Which has preferable valuation and earnings, EXFY or DH? Expensify has higher earnings, but lower revenue than Definitive Healthcare. Expensify is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExpensify$150.69M1.57-$41.46M-$0.18-17.05Definitive Healthcare$251.41M1.88-$202.39M-$3.10-1.32 Do analysts recommend EXFY or DH? Expensify presently has a consensus target price of $2.83, indicating a potential downside of 7.71%. Definitive Healthcare has a consensus target price of $5.81, indicating a potential upside of 41.77%. Given Definitive Healthcare's higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than Expensify.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Expensify 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Definitive Healthcare 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18 Which has more volatility & risk, EXFY or DH? Expensify has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Does the MarketBeat Community favor EXFY or DH? Definitive Healthcare received 7 more outperform votes than Expensify when rated by MarketBeat users. However, 30.36% of users gave Expensify an outperform vote while only 28.92% of users gave Definitive Healthcare an outperform vote. CompanyUnderperformOutperformExpensifyOutperform Votes1730.36% Underperform Votes3969.64% Definitive HealthcareOutperform Votes2428.92% Underperform Votes5971.08% Do insiders & institutionals believe in EXFY or DH? 68.4% of Expensify shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 17.3% of Expensify shares are held by company insiders. Comparatively, 14.8% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is EXFY or DH more profitable? Expensify has a net margin of -11.81% compared to Definitive Healthcare's net margin of -142.38%. Definitive Healthcare's return on equity of 1.76% beat Expensify's return on equity.Company Net Margins Return on Equity Return on Assets Expensify-11.81% -14.72% -8.89% Definitive Healthcare -142.38%1.76%1.12% Does the media prefer EXFY or DH? In the previous week, Expensify had 6 more articles in the media than Definitive Healthcare. MarketBeat recorded 6 mentions for Expensify and 0 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.00 beat Expensify's score of -0.48 indicating that Definitive Healthcare is being referred to more favorably in the news media. Company Overall Sentiment Expensify Neutral Definitive Healthcare Neutral SummaryDefinitive Healthcare beats Expensify on 10 of the 18 factors compared between the two stocks. Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Definitive Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DH vs. The Competition Export to ExcelMetricDefinitive HealthcarePrepackaged software IndustryMedical SectorNASDAQ ExchangeMarket Cap$482.89M$25.43B$5.07B$8.89BDividend YieldN/A2.29%4.99%4.07%P/E Ratio-1.3257.0483.5712.93Price / Sales1.889.121,220.3088.33Price / Cash1.3587.7739.4636.25Price / Book0.688.706.936.25Net Income-$202.39M$444.73M$119.12M$225.93M7 Day Performance-8.07%-0.07%-1.83%-1.32%1 Month Performance-8.07%4.17%-3.64%0.60%1 Year Performance-48.23%23.90%31.64%26.23% Definitive Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHDefinitive Healthcare1.7322 of 5 stars$4.10-1.9%$5.81+41.8%-50.3%$482.89M$251.41M-1.32970EXFYExpensify0.8277 of 5 stars$3.07+10.8%$2.83-7.7%+23.3%$213.72M$150.69M0.00133Insider TradeGap UpTUYATuya2.3741 of 5 stars$1.57-1.3%$2.70+72.0%-12.3%$801.98M$229.99M0.001,465LPSNLivePerson1.6958 of 5 stars$0.84flat$1.25+48.6%-73.5%$75.75M$401.98M-0.551,095JAMFJamfN/A$14.15-4.1%$26.43+86.8%-17.7%$1.88B$560.57M0.002,767NABLN-able2.6517 of 5 stars$10.16+0.4%$15.67+54.2%-14.3%$1.88B$421.88M50.801,584OPRAOpera4.6298 of 5 stars$19.46-1.4%$24.75+27.2%+54.9%$1.75B$396.83M9.88630PDPagerDuty3.7603 of 5 stars$18.85+0.9%$21.82+15.7%-14.9%$1.74B$430.70M-21.181,182IASIntegral Ad Science4.1215 of 5 stars$10.85+2.0%$15.70+44.7%-24.5%$1.73B$474.37M54.25880MLNKMeridianLink1.6662 of 5 stars$22.06-0.6%$22.90+3.8%+18.3%$1.68B$303.62M0.00620SPTSprout Social3.1006 of 5 stars$29.63+1.9%$45.62+53.9%-46.5%$1.67B$333.64M0.001,383Analyst ForecastNews Coverage Related Companies and Tools Related Companies EXFY Alternatives TUYA Alternatives LPSN Alternatives JAMF Alternatives NABL Alternatives OPRA Alternatives PD Alternatives IAS Alternatives MLNK Alternatives SPT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Definitive Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.